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and Geriatrics (Klinika Reumatologii, Chorób 
Wewnętrznych i Geriatrii)
7 National Institute of Geriatrics, Rheumatolo‑
gy and Rehabilitation, Warsaw (Narodowy Insty‑
tut Geriatrii Reumatologii i Rehabilitacji, Warsza‑
wa): Department of Rheumatology (Klinika i Po‑
liklinika Reumatologii); Department of Early Ar‑
thritis (Klinika Wczesnego Zapalenia Stawów); 
and Department of Connective Tissue Diseas‑
es (Klinika Układowych Chorób Tkanki Łącznej)
8 Central Clinical Hospital of the Ministry of 
the Interior and Administration in Warsaw (Cen‑
tralny Szpital Kliniczny MSWiA, Warszawa): De‑
partment of Internal Diseases and Rheumatology 
(Klinika Chorób Wewnętrznych i Reumatologii)
9 Military Institute of Medicine, Warsaw (Wojs‑
kowy Instytut Medyczny, Warszawa): Department 
of Internal Medicine and Rheumatology (Klinika 
Chorób Wewnętrznych i Reumatologii).
The POLVAS registry is designed for research 
purposes and includes retrospective and prospec‑
tive databases. The retrospective part concen‑
trates on epidemiology, clinical picture, as well as 
treatment safety and efficacy in the current rou‑
tine care of vasculitis patients. The major aims of 
the prospective part include studies on pathogen‑
esis, diagnostic and disease activity markers in 
serum, treatment efficacy and safety, long ‑term 
disease outcome including clinical and social con‑
sequences, and participation in clinical trials on 
novel therapeutic modalities in various vasculi‑
tis syndromes.
The members of the Consortium will also cre‑
ate vasculitis reference centers to offer the best 
possible diagnostic and therapeutic care for pa‑
tients with vasculitis and to promote recent and 
future international vasculitis recommendations 
throughout the country.3,4
POLVAS will closely cooperate with other vas‑
culitis registries created across Europe within 
the European Vasculitis Society (EUVAS) collab‑
orative network. In association with the regis‑
try, a website for patients has also been created 
(www.zapalenianaczyn.pl) in order to provide 
a set of useful information about the various as‑
pects of vasculitis syndromes.
Those who are interested in the cooperation 
with POLVAS are invited to visit the webpage 
at http://medicine.krakow.pl/POLVAS or con‑
tact the registry at POLVAS@cm ‑uj.krakow.pl.
To the Editor In 2014, we informed readers of this 
journal about the initiative to establish a Polish 
vasculitis registry.1 According to the recommen‑
dations of the European Union Committee of Ex‑
perts on Rare Diseases (EUCERD), such registries 
should be created to help elucidate the numerous 
gaps in our knowledge about medical and social im‑
pact of these diseases on the health care system.2
It is now our pleasure to announce that the Sci‑
entific Consortium of the Polish Vasculitis Reg‑
istry (Konsorcjum Naukowe Polskiego Rejest‑
ru Zapaleń Naczyń – POLVAS) has been created. 
The members of the Consortium include:
1 Jagiellonian University Medical College, 
Kraków (Leader) (Uniwersytet Jagielloński, Col‑
legium Medicum): 2nd Department of Internal 
Medicine (II Katedra Chorób Wewnętrznych im. 
prof. Andrzeja Szczeklika)
2 Medical University of Gdańsk (Gdański Uniw‑
ersytet Medyczny): Department of Internal Med‑
icine, Connective Tissue Diseases and Geriatrics 
(Katedra i Klinika Chorób Wewnętrznych, Chorób 
Tkanki Łącznej i Geriatrii); Department of Ne‑
phrology, Transplantology and Internal Diseas‑
es (Katedra i Klinika Nefrologii, Transplantolo‑
gii i Chorób Wewnętrznych)
3 Wroclaw Medical University (Uniwersytet 
Medyczny im. Piastów Śląskich, Wrocław): De‑
partment of Rheumatology and Internal Med‑
icine (Katedra i Klinika Reumatologii i Chorób 
Wewnętrznych) and Department of Nephrology 
and Transplantation Medicine (Katedra i Klinika 
Nefrologii i Medycyny Transplantacyjnej)
4 Medical University of Silesia (Śląski Uniwer‑
sytet Medyczny, Katowice): Department of In‑
ternal Medicine and Metabolic Diseases (Klini‑
ka Chorób Wewnętrznych i Metabolicznych); De‑
partment of Nephrology, Transplantation and In‑
ternal Medicine (Klinika Nefrologii, Transplanto‑
logii i Chorób Wewnętrznych); and Department 
of Internal Medicine and Rheumatology (Katedra 
i Klinika Chorób Wewnętrznych i Reumatologii)
5 Medical University of Lublin (Uniwersytet Me‑
dyczny, Lublin): Department of Rheumatology 
and Connective Tissue Diseases (Katedra i Klini‑
ka Reumatologii i Układowych Chorób Tkanki 
Łącznej)
6 Pomeranian Medical University in Szczecin 
(Pomorski Uniwersytet Medyczny, Szczecin): De‑
partment of Rheumatology, Internal Medicine 
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